Drugs to Avoid in Labouring Women with Bronchial Asthma
Bronchial asthma is a state of hyperreactive airways prone to bronchospasm. During labour and delivery, several commonly used obstetric drugs have known bronchoconstrictor or histamine-releasing properties and must be used cautiously or avoided in asthmatic patients, while others are actually bronchodilators and are safe (or even preferred).
Analysis of Each Option
- 1. Opioid analgesics: Avoided. Opioids such as morphine and pethidine cause direct mast cell degranulation and histamine release, which can precipitate bronchospasm and worsen respiratory status in an asthmatic patient in labour.
- 2. Prostaglandin F2α: Avoided. PGF2α (used for uterine atony/PPH, e.g., carboprost) is a potent bronchoconstrictor and smooth-muscle stimulant. It is contraindicated in asthmatics because it can trigger severe, sometimes fatal, bronchospasm.
- 3. Prostaglandin E1: Safe — not to be avoided. Unlike PGF2α, prostaglandin E1 (misoprostol) and E2 analogues cause bronchial smooth muscle relaxation (bronchodilation) rather than constriction. They are therefore considered safe for cervical ripening/induction and uterotonic use even in women with asthma.
- 4. Ergometrine: Avoided. Ergometrine (used for active management of the third stage of labour) can provoke bronchospasm and is also associated with vasoconstriction; it is best avoided in asthmatic and hypertensive patients.
Conclusion
The drugs that should be avoided in labouring women with bronchial asthma are Opioid analgesics (1), Prostaglandin F2α (2), and Ergometrine (4), since each can precipitate bronchospasm. Prostaglandin E1 (3) is a bronchodilator and is safe to use, so it is correctly excluded.
Therefore, the correct answer is 1, 2 and 4.